Pharmacokinetic Similarity of ABP 654, an Ustekinumab Biosimilar Candidate: Results from a Randomized, Double-blind Study in Healthy Subjects.
Saved in:
| Title: | Pharmacokinetic Similarity of ABP 654, an Ustekinumab Biosimilar Candidate: Results from a Randomized, Double-blind Study in Healthy Subjects. |
|---|---|
| Authors: | Chow V; Amgen Inc., Thousand Oaks, CA, USA., Mytych DT; Amgen Inc., Thousand Oaks, CA, USA., Das S; Amgen Inc., Thousand Oaks, CA, USA., Franklin J; Amgen Inc., Thousand Oaks, CA, USA. |
| Source: | Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2023 Sep; Vol. 12 (9), pp. 863-873. Date of Electronic Publication: 2023 Jul 07. |
| Publication Type: | Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37415567 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Pharmacokinetic Similarity of ABP 654, an Ustekinumab Biosimilar Candidate: Results from a Randomized, Double-blind Study in Healthy Subjects. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chow+V%22">Chow V</searchLink>; Amgen Inc., Thousand Oaks, CA, USA.<br /><searchLink fieldCode="AU" term="%22Mytych+DT%22">Mytych DT</searchLink>; Amgen Inc., Thousand Oaks, CA, USA.<br /><searchLink fieldCode="AU" term="%22Das+S%22">Das S</searchLink>; Amgen Inc., Thousand Oaks, CA, USA.<br /><searchLink fieldCode="AU" term="%22Franklin+J%22">Franklin J</searchLink>; Amgen Inc., Thousand Oaks, CA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101572899%22">Clinical pharmacology in drug development</searchLink> [Clin Pharmacol Drug Dev] 2023 Sep; Vol. 12 (9), pp. 863-873. <i>Date of Electronic Publication: </i>2023 Jul 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101572899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2160-7648 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222160763X%22">2160763X </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Drug Dev <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37415567 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cpdd.1301 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 863 Titles: – TitleFull: Pharmacokinetic Similarity of ABP 654, an Ustekinumab Biosimilar Candidate: Results from a Randomized, Double-blind Study in Healthy Subjects. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chow V – PersonEntity: Name: NameFull: Mytych DT – PersonEntity: Name: NameFull: Das S – PersonEntity: Name: NameFull: Franklin J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2023 Sep Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2160-7648 Numbering: – Type: volume Value: 12 – Type: issue Value: 9 Titles: – TitleFull: Clinical pharmacology in drug development Type: main |
| ResultId | 1 |
